Heungkuk Securities
Overview
Heungkuk Securities is a South Korean securities company and a member of the Taekwang Group. Its main business includes investment brokerage, trading, underwriting of debt securities, and investment banking (IB) services such as advisory for project financing and real estate. It also provides stock brokerage and sells financial products to institutional and corporate clients. The firm is known to participate in direct investments, such as its role in the Series B funding for Avelos Therapeutics.
Portfolio Companies
8
Website
heungkuksec.co.krInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Amyloid Solution Inc. | May 2022 | Series C | Co-investor |
| SCAI Therapeutics | Jul 2021 | Series B | Co-investor |
| Daan Biotherapeutics | Jan 2024 | Series A | Co-investor |
| Avelos Therapeutics | Apr 2024 | Series B | Co-investor |
| De Novo Biotherapeutics | Nov 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Heungkuk Securities based?
Heungkuk Securities is headquartered in Seoul, Seoul, South Korea.
When was Heungkuk Securities founded?
Founding year information for Heungkuk Securities is not publicly available.
How many portfolio companies does Heungkuk Securities have?
Heungkuk Securities has 8 portfolio companies in Caplight's dataset.
What are some companies in Heungkuk Securities's portfolio?
Portfolio companies visible on Caplight include Amyloid Solution Inc., SCAI Therapeutics, Daan Biotherapeutics, Avelos Therapeutics, De Novo Biotherapeutics.
What was Heungkuk Securities's most recent investment shown here?
Heungkuk Securities's most recent investment in this portfolio sample was in Avelos Therapeutics in 2024.
What sectors does Heungkuk Securities focus on?
Heungkuk Securities focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Heungkuk Securities focus on?
Heungkuk Securities typically invests at the MultiStage stage.